Prevention, screening, and treatment for heavy drinking and alcohol use disorder
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Summary Heavy drinking and alcohol use disorder (AUD) are major public health problems. Practitioners not specializing in alcohol treatment are often unaware of the guidelines for preventing, identifying, and treating heavy drinking and AUD. However, a consensus exists that clinically useful and valuable tools are available to address these issues. Here, we provide a critical review of existing information and recent developments in these areas. We also include information on heavy drinking and AUD among individuals with co-occurring psychiatric disorders, including drug use disorders. Areas covered include prevention; screening, brief intervention, and referral for treatment (SBIRT); evidence-based behavioral interventions; medication-assisted treatment; technology-based interventions (eHealth and mHealth); and population-level interventions. We also discuss the key issues that remain for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SAUNDERS, J. B., AASLAND, O. G., BABOR, T. F., DE LA FUENTE, J. R., & GRANT, M. (1993) · Addiction · doi:10.1111/j.1360-0443.1993.tb02093.x · Cited by 13,597
Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.7.830 · Cited by 2,908
Self-citationCross-national prevalence and risk factors for suicidal ideation, plans and attempts
Nock, M. K., Borges, G., Bromet, E. J., Alonso, J., Angermeyer, M., Beautrais, A., Bruffaerts, R., Chiu, W. T., de Girolamo, G., Gluzman, S., et al. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.107.040113 · Cited by 2,654
Grant, B. F., Goldstein, R. B., Saha, T. D., Chou, S. P., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Smith, S. M., Huang, B., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.0584 · Cited by 2,556
Self-citation(1997) · Journal of Studies on Alcohol · doi:10.15288/jsa.1997.58.7 · Cited by 1,905
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Hettema, J., Steele, J., & Miller, W. R. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143833 · Cited by 1,803
Epidemiology of Adult DSM-5 Major Depressive Disorder and Its Specifiers in the United States
Hasin, D. S., Sarvet, A. L., Meyers, J. L., Saha, T. D., Ruan, W. J., Stohl, M., & Grant, B. F. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4602 · Cited by 1,737
Self-citationEffectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Moodie, R., Stuckler, D., Monteiro, C., Sheron, N., Neal, B., Thamarangsi, T., Lincoln, P., & Casswell, S. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62089-3 · Cited by 1,663
Research works printed but not linked: 94
- 2018, Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 392, 1015, 10.1016/S0140-6736(18)31310-2 · DOI · Paper page
- Parker, 2008, Diagnosis and management of alcohol use disorders, BMJ, 336, 496, 10.1136/bmj.39483.457708.80 · DOI
- Saunders, 2017, Substance use and addictive disorders in DSM-5 and ICD 10 and the draft ICD 11, Curr Opin Psychiatry, 30, 227, 10.1097/YCO.0000000000000332 · DOI · Paper page
- Saunders, 2018, Alcohol use disorders in the draft ICD-11, and how they compare with DSM-5, Current Addiction Reports, 5, 257, 10.1007/s40429-018-0197-8 · DOI
- Hasin, 2017, Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population, Lancet Psychiatry, 4, 469, 10.1016/S2215-0366(17)30130-X · DOI · Paper page
- Rehm, 2003, Alcohol-related morbidity and mortality, Alcohol Res Health, 27, 39
- Rehm, 1996, Alcohol and all-cause mortality, Int J Epidemiol, 25, 215, 10.1093/ije/25.1.215 · doi:10.1093/ije/25.1.215
- Lewis-Laietmark, 2017, The effects of alcohol-related harms to others on self-perceived mental well-being in a Canadian sample, Int J Public Health, 62, 669, 10.1007/s00038-016-0924-7 · DOI
- Greenfield, 2015, Trends in alcohol's harms to others (AHTO) and co-occurrence of family-related AHTO: the four US national alcohol surveys, 2000–2015, Subst Abuse, 9, 23
- Cohen, 2007, Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions, Drug Alcohol Depend, 86, 214, 10.1016/j.drugalcdep.2006.06.008 · DOI · Paper page
- Shield, 2014, The potential impact of increased treatment rates for alcohol dependence in the United Kingdom in 2004, BMC Health Serv Res, 14, 53, 10.1186/1472-6963-14-53 · DOI · Paper page
- Lim, 2012, A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380, 2224, 10.1016/S0140-6736(12)61766-8 · DOI · Paper page
- Stigler, 2011, School-based programs to prevent and reduce alcohol use among youth, Alcohol Res Health, 34, 157
- Martineau, 2013, Population-level interventions to reduce alcohol-related harm: an overview of systematic reviews, Prev Med, 57, 278, 10.1016/j.ypmed.2013.06.019 · DOI · Paper page
- Burton, 2017, A rapid evidence review of the effectiveness and cost-effectiveness of alcohol control policies: an English perspective, Lancet, 389, 1558, 10.1016/S0140-6736(16)32420-5 · DOI · Paper page
- Watkins, 2017, Collaborative care for opioid and alcohol use disorders in primary care: the SUMMIT randomized clinical trial, JAMA Intern Med, 177, 1480, 10.1001/jamainternmed.2017.3947 · DOI · Paper page
- Willenbring, 2009, Helping patients who drink too much: an evidence-based guide for primary care clinicians, Am Fam Physician, 80, 44
- Curry, 2018, Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force recommendation statement, JAMA, 320, 1899, 10.1001/jama.2018.16789 · DOI · Paper page
- Whitlock, 2004, Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the US Preventive Services Task Force, Ann Intern Med, 140, 557, 10.7326/0003-4819-140-7-200404060-00017 · DOI · Paper page
- Chi, 2017, Alcohol brief intervention in primary care: blood pressure outcomes in hypertensive patients, J Subst Abuse Treat, 77, 45, 10.1016/j.jsat.2017.03.009 · DOI
- Ray, 2019, State-of-the-art behavioral and pharmacological treatments for alcohol use disorder, Am J Drug Alcohol Abuse, 45, 124, 10.1080/00952990.2018.1528265 · DOI · Paper page
- Pringle, 2012, Equipping residents to address alcohol and drug abuse: the national SBIRT residency training project, J Grad Med Educ, 4, 58, 10.4300/JGME-D-11-00019.1 · DOI
- Keyes, 2010, Stigma and treatment for alcohol disorders in the United States, Am J Epidemiol, 172, 1364, 10.1093/aje/kwq304 · DOI · Paper page
- Probst, 2015, Transition probabilities for four states of alcohol use in adolescence and young adulthood: what factors matter when?, Addiction, 110, 1272, 10.1111/add.12985 · DOI
- McKnight-Eily, 2014, Vital signs: communication between health professionals and their patients about alcohol use, 44 states and the District of Columbia, 2011, MMWR Morb Mortal Wkly Rep, 63, 16
- Bradley, 2011, Quality concerns with routine alcohol screening in VA clinical settings, J Gen Intern Med, 26, 299, 10.1007/s11606-010-1509-4 · DOI
- Bradley, 2006, Implementation of evidence-based alcohol screening in the Veterans Health Administration, Am J Manag Care, 12, 597
- Makdissi, 2013, Care for hospitalized patients with unhealthy alcohol use: a narrative review, Addict Sci Clin Pract, 8, 11, 10.1186/1940-0640-8-11 · DOI
- Palmer, 2019, Barriers faced by physicians in screening for substance use disorders among adolescents, Psychiatr Serv, 70, 409, 10.1176/appi.ps.201800427 · DOI
- Satre, 2008, Computerized screening for alcohol and drug use among adults seeking outpatient psychiatric services, Psychiatr Serv, 59, 441, 10.1176/ps.2008.59.4.441 · doi:10.1176/ps.2008.59.4.441
- Higgins, 1999, Contingency management: incentives for sobriety, Alcohol Res Health, 23, 122
- Petry, 2000, Give them prizes, and they will come: contingency management for treatment of alcohol dependence, J Consult Clin Psychol, 68, 250, 10.1037/0022-006X.68.2.250 · DOI · Paper page
- 1998, Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes, Alcohol Clin Exp Res, 22, 1300
- 1998, Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment, J Stud Alcohol, 59, 631, 10.15288/jsa.1998.59.631 · DOI · Paper page
- Lenaerts, 2014, Continuing care for patients with alcohol use disorders: a systematic review, Drug Alcohol Depend, 135, 9, 10.1016/j.drugalcdep.2013.10.030 · DOI
- Foxcroft, 2016, Motivational interviewing for the prevention of alcohol misuse in young adults, Cochrane Database Syst Rev, 7
- Gaume, 2009, Counselor skill influences outcomes of brief motivational interventions, J Subst Abuse Treat, 37, 151, 10.1016/j.jsat.2008.12.001 · DOI
- Bertholet, 2014, Do brief alcohol motivational interventions work like we think they do?, Alcohol Clin Exp Res, 38, 853, 10.1111/acer.12274 · DOI
- Wu, 2016, Cognitive behavioral therapy and motivational enhancement therapy, Child Adolesc Psychiatr Clin N Am, 25, 629, 10.1016/j.chc.2016.06.002 · DOI
- Carroll, 2004, Behavioral therapies for co-occurring substance use and mood disorders, Biol Psychiatry, 56, 778, 10.1016/j.biopsych.2004.07.010 · DOI
- Kelly, 2012, Treatment of substance abusing patients with comorbid psychiatric disorders, Addict Behav, 37, 11, 10.1016/j.addbeh.2011.09.010 · DOI · Paper page
- Garbutt, 2005, Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial, JAMA, 293, 1617, 10.1001/jama.293.13.1617 · DOI · Paper page
- Rosner, 2010, Acamprosate for alcohol dependence, Cochrane Database Syst Rev, 8
- Pierce, 2018, Efficacy, tolerability, and safety of low-dose and high-dose baclofen in the treatment of alcohol dependence: a systematic review and meta-analysis, Eur Neuropsychopharmacol, 28, 795, 10.1016/j.euroneuro.2018.03.017 · DOI · Paper page
- Blodgett, 2014, A meta-analysis of topiramate's effects for individuals with alcohol use disorders, Alcohol Clin Exp Res, 38, 1481, 10.1111/acer.12411 · DOI · Paper page
- Knapp, 2015, Zonisamide, topiramate, and levetiracetam: efficacy and neuropsychological effects in alcohol use disorders, J Clin Psychopharmacol, 35, 34, 10.1097/JCP.0000000000000246 · DOI · Paper page
- Froehlich, 2016, Combining varenicline (Chantix) with naltrexone decreases alcohol drinking more effectively than does either drug alone in a rodent model of alcoholism, Alcohol Clin Exp Res, 40, 1961, 10.1111/acer.13157 · DOI
- Erwin, 2014, Varenicline in the treatment of alcohol use disorders, Ann Pharmacother, 48, 1445, 10.1177/1060028014545806 · DOI
- Lynch, 2011, Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse, Psychopharmacology (Berl), 217, 3, 10.1007/s00213-011-2253-0 · DOI · Paper page
- Moore, 2014, Acute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) rats, Exp Clin Psychopharmacol, 22, 35, 10.1037/a0035215 · DOI
- Johnson, 2000, Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial, JAMA, 284, 963, 10.1001/jama.284.8.963 · DOI · Paper page
- Kranzler, 2003, Effects of ondansetron in early- versus late-onset alcoholics: a prospective, open-label study, Alcohol Clin Exp Res, 27, 1150, 10.1097/01.ALC.0000075547.77464.76 · DOI
- Kishi, 2013, Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials, J Clin Psychiatry, 74, e642, 10.4088/JCP.12r08178 · DOI
- Guardia, 2011, A double-blind, placebo-controlled, randomized pilot study comparing quetiapine with placebo, associated to naltrexone, in the treatment of alcohol-dependent patients, Addict Behav, 36, 265, 10.1016/j.addbeh.2010.11.006 · DOI
- Nunes, 2004, Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis, JAMA, 291, 1887, 10.1001/jama.291.15.1887 · DOI · Paper page
- Soyka, 2017, Pharmacotherapy of alcoholism: an update on approved and off-label medications, Expert Opin Pharmacother, 18, 1187, 10.1080/14656566.2017.1349098 · DOI · Paper page
- Krampe, 2006, Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome, Alcohol Clin Exp Res, 30, 86, 10.1111/j.1530-0277.2006.00013.x · DOI
- Soyka, 2017, Guidelines for biological treatment of substance use and related disorders, part 1: alcoholism, first revision, World J Biol Psychiatry, 18, 86, 10.1080/15622975.2016.1246752 · DOI
- Brewer, 2017, Supervised disulfiram's superior effectiveness in alcoholism treatment: ethical, methodological, and psychological aspects, Alcohol Alcohol, 52, 213
- O’Malley, 1992, Naltrexone and coping skills therapy for alcohol dependence: a controlled study, Arch Gen Psychiatry, 49, 881, 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- Mark, 2009, Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty, Drug Alcohol Depend, 99, 345, 10.1016/j.drugalcdep.2008.07.018 · DOI · Paper page
- Ponce Martinez, 2016, Pharmacotherapy for alcohol use disorders: physicians’ perceptions and practices, Front Psychiatry, 7, 182, 10.3389/fpsyt.2016.00182 · DOI
- Harris, 2013, Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers, Psychol Serv, 10, 410, 10.1037/a0030949 · DOI
- Kranzler, 2004, Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial, Alcohol Clin Exp Res, 28, 1051, 10.1097/01.ALC.0000130804.08397.29 · DOI · Paper page
- Edelman, 2019, Efficacy of extended-release naltrexone on HIV-related and drinking outcomes among HIV-positive patients: a randomized-controlled trial, AIDS Behav, 23, 211, 10.1007/s10461-018-2241-z · DOI
- Springer, 2017, Extended-release naltrexone reduces alcohol consumption among released prisoners with HIV disease as they transition to the community, Drug Alcohol Depend, 174, 158, 10.1016/j.drugalcdep.2017.01.026 · DOI
- Crits-Christoph, 2015, Extended-release naltrexone for alcohol and opioid problems in Missouri parolees and probationers, J Subst Abuse Treat, 56, 54, 10.1016/j.jsat.2015.03.003 · DOI
- Kalk, 2014, The clinical pharmacology of acamprosate, Br J Clin Pharmacol, 77, 315, 10.1111/bcp.12070 · DOI
- Paille, 2014, Nalmefene: a new approach to the treatment of alcohol dependence, Subst Abuse Rehabil, 5, 87, 10.2147/SAR.S45666 · DOI
- Litten, 2016, Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety, Subst Abus, 37, 286, 10.1080/08897077.2015.1133472 · DOI · Paper page
- Ducharme, 2006, Trends in the adoption of medications for alcohol dependence, J Clin Psychopharmacol, 26, S13, 10.1097/01.jcp.0000246209.18777.14 · DOI
- Knudsen, 2016, Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: data from a national sample of treatment organizations, Subst Abus, 37, 230, 10.1080/08897077.2015.1028699 · DOI
- Knudsen, 2014, The transition to medication adoption in publicly funded substance use disorder treatment programs: organizational structure, culture, and resources, J Stud Alcohol Drugs, 75, 476, 10.15288/jsad.2014.75.476 · DOI
- Anton, 2012, The Alcohol Clinical Trials Initiative (ACTIVE): purpose and goals for assessing important and salient issues for medications development in alcohol use disorders, Neuropsychopharmacology, 37, 402, 10.1038/npp.2011.182 · DOI
- Witkiewitz, 2015, Recommendations for the design and analysis of treatment trials for alcohol use disorders, Alcohol Clin Exp Res, 39, 1557, 10.1111/acer.12800 · DOI · Paper page
- DeMartini, 2014, Predictors of pretreatment commitment to abstinence: results from the COMBINE study, J Stud Alcohol Drugs, 75, 438, 10.15288/jsad.2014.75.438 · DOI
- Maisto, 2018, Course of remission from and relapse to heavy drinking following outpatient treatment of alcohol use disorder, Drug Alcohol Depend, 187, 319, 10.1016/j.drugalcdep.2018.03.011 · DOI
- Mann, 2017, Can reduced drinking be a viable goal for alcohol dependent patients?, World Psychiatry, 16, 325, 10.1002/wps.20476 · DOI
- Meredith, 2015, Smartphone applications to reduce alcohol consumption and help patients with alcohol use disorder: a state-of-the-art review, Adv Health Care Technol, 1, 47
- Tofighi, 2018, The role of technology-based interventions for substance use disorders in primary care: a review of the literature, Med Clin North Am, 102, 715, 10.1016/j.mcna.2018.02.011 · DOI
- Nesvag, 2018, Feasibility and effects of digital interventions to support people in recovery from substance use disorders: systematic review, J Med Internet Res, 20, 10.2196/jmir.9873 · DOI · Paper page
- Naslund, 2017, Digital technology for treating and preventing mental disorders in low-income and middle-income countries: a narrative review of the literature, Lancet Psychiatry, 4, 486, 10.1016/S2215-0366(17)30096-2 · DOI · Paper page
- Dennis, 2015, A pilot study to examine the feasibility and potential effectiveness of using smartphones to provide recovery support for adolescents, Subst Abus, 36, 486, 10.1080/08897077.2014.970323 · DOI · Paper page
- Aharonovich, 2017, HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: a randomized pilot trial, J Subst Abuse Treat, 83, 15, 10.1016/j.jsat.2017.09.013 · DOI
- Hasin, 2013, Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement, Addiction, 108, 1230, 10.1111/add.12127 · DOI
- Muroff, 2017, Use of a smartphone recovery tool for Latinos with co-occurring alcohol and other drug disorders and mental disorders, J Dual Diagn, 13, 280, 10.1080/15504263.2017.1348649 · DOI
- Kazemi, 2017, A systematic review of the mHealth interventions to prevent alcohol and substance abuse, J Health Commun, 22, 413, 10.1080/10810730.2017.1303556 · DOI · Paper page
- Fell, 2014, The effectiveness of a 0?05 blood alcohol concentration (BAC) limit for driving in the United States, Addiction, 109, 869, 10.1111/add.12365 · doi:10.1111/add.12365
- Elder, 2010, The effectiveness of tax policy interventions for reducing excessive alcohol consumption and related harms, Am J Prev Med, 38, 217, 10.1016/j.amepre.2009.11.005 · DOI · Paper page
- Wagenaar, 2010, Effects of alcohol tax and price policies on morbidity and mortality: a systematic review, Am J Public Health, 100, 2270, 10.2105/AJPH.2009.186007 · DOI · Paper page
- Warren, 2015, A review of the history of attitudes toward drinking in pregnancy, Alcohol Clin Exp Res, 39, 1110, 10.1111/acer.12757 · DOI
- Casswell, 2009, Reducing harm from alcohol: call to action, Lancet, 373, 2247, 10.1016/S0140-6736(09)60745-5 · DOI · Paper page
- Mann, 2018, Precision medicine in alcohol dependence: a controlled trial testing pharmacotherapy response among reward and relief drinking phenotypes, Neuropsychopharmacology, 43, 891, 10.1038/npp.2017.282 · DOI
- Kranzler, 2014, Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism, Am J Psychiatry, 171, 445, 10.1176/appi.ajp.2013.13081014 · DOI · Paper page
Cited by
Psychiatric comorbidities in alcohol use disorder
Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30222-6 · Cited by 444
Self-citationRepurposing Semaglutide and Liraglutide for Alcohol Use Disorder
Lähteenvuo, M., Tiihonen, J., Solismaa, A., Tanskanen, A., Mittendorfer-Rutz, E., & Taipale, H. (2025) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2024.3599 · Cited by 134
Alcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.010 · Cited by 102
Robinson, D. J., Hanson, K., Jain, A. B., Kichler, J. C., Mehta, G., Melamed, O. C., Vallis, M., Bajaj, H. S., Barnes, T., Gilbert, J., et al. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.04.009 · Cited by 73
van der Westhuizen, C., Malan, M., Naledi, T., Roelofse, M., Myers, B., Stein, D. J., Lahri, S., & Sorsdahl, K. (2021) · Addiction Science & Clinical Practice · doi:10.1186/s13722-021-00239-5 · Cited by 13
“These aspects are common in other SBIRT programmes, and are often delivered utilising a motivational interviewing style, as in the Teachable Moment programme [38].”
Method
Metadata
- Authors
- Knox, J., Hasin, D. S., Larson, F. R. R., & Kranzler, H. R.
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2019-12
- Volume
- 6
- Issue
- 12
- Pages
- 1054-1067
- ISSN
- 2215-0366 (ISSN-L)
- OpenAlex
- W2980844170
- Cited by
- 141
- References
- 72
- FWCI
- 8.61
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Funders
- New York State Psychiatric Institute
- U.S. Department of Veterans Affairs
- National Institute on Alcohol Abuse and Alcoholism (R01AA021164, R01AA023192, R01AA025309)
- National Institute on Drug Abuse (T32DA031099)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prevention, screening, and treatment for heavy drinking and alcohol use disorder. https://app.cochat.ai/papers/10.1016/s2215-0366(19)30213-5
- The paper
- Knox, J., Hasin, D. S., Larson, F. R. R., & Kranzler, H. R. (2019). Prevention, screening, and treatment for heavy drinking and alcohol use disorder. The Lancet Psychiatry. https://doi.org/10.1016/s2215-0366(19)30213-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.